Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer (Q39323181)

11 September 2017

Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer (English)

1 reference

11 September 2017

Jingdong Zhang

1

1 reference

11 September 2017

Peng Wang

2

1 reference

11 September 2017

Mark Dykstra

3

1 reference

11 September 2017

Pascale Gelebart

4

1 reference

11 September 2017

David Williams

5

1 reference

11 September 2017

Robert Ingham

6

1 reference

11 September 2017

Esther Ekpe Adewuyi

7

1 reference

11 September 2017

Raymond Lai

8

1 reference

11 September 2017

Todd McMullen

9

1 reference

11 September 2017

4 September 2012

1 reference

11 September 2017

1 reference

11 September 2017

228

1 reference

11 September 2017

2

1 reference

11 September 2017

241-250

1 reference

Epidemiology of thyroid nodules

11 September 2017

1 reference

Fine-needle aspiration biopsy of the thyroid: an appraisal

21 January 2018

1 reference

Summary statement: utility of molecular marker testing in thyroid cancer

21 January 2018

1 reference

Patterns of failure in differentiated carcinoma of the thyroid based on risk groups

21 January 2018

1 reference

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

Pattern of nodal metastasis for primary and reoperative thyroid cancer

21 January 2018

1 reference

Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma

21 January 2018

1 reference

The role of lymphadenectomy in the management of papillary carcinoma of the thyroid

21 January 2018

1 reference

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study

21 January 2018

1 reference

Recent developments in the clinical application of thyroid cancer biomarkers

21 January 2018

1 reference

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

21 January 2018

1 reference

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.

21 January 2018

1 reference

Thyroid carcinoma: molecular pathways and therapeutic targets

21 January 2018

1 reference

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

21 January 2018

1 reference

Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.

21 January 2018

1 reference

Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.

21 January 2018

1 reference

Clinical-molecular factors predicting response and survival for tyrosine-kinase inhibitors.

21 January 2018

1 reference

PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.

21 January 2018

1 reference

Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53.

21 January 2018

1 reference

Molecular pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.

21 January 2018

1 reference

Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas

21 January 2018

1 reference

Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer.

21 January 2018

1 reference

Targeted therapies for thyroid tumors.

21 January 2018

1 reference

Multikinase inhibitors: a new option for the treatment of thyroid cancer.

21 January 2018

1 reference

Targeted molecular therapies in thyroid carcinoma

21 January 2018

1 reference

Phase II trial of sorafenib in advanced thyroid cancer

21 January 2018

1 reference

Phase II trial of sorafenib in metastatic thyroid cancer

21 January 2018

1 reference

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation

21 January 2018

1 reference

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr

21 January 2018

1 reference

Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential.

21 January 2018

1 reference

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification

21 January 2018

1 reference

The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms

21 January 2018

1 reference

Twist1-induced invadopodia formation promotes tumor metastasis.

21 January 2018

1 reference

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers

21 January 2018

1 reference

PDGF: the nuts and bolts of signalling toolbox

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4069

1 reference

11 September 2017

1 reference